# Evaluation of a Transfusion Therapy Using Whole Blood in the Management of Coagulopathy in Patients With Acute Traumatic Hemorrhage

> **NCT04431999** · PHASE3 · COMPLETED · sponsor: **Direction Centrale du Service de Santé des Armées** · enrollment: 200 (actual)

## Conditions studied

- Trauma
- Acute Hemorrhage
- Coagulopathy

## Interventions

- **DRUG:** Whole blood transfusion
- **DRUG:** Fractionated blood products transfusion

## Key facts

- **NCT ID:** NCT04431999
- **Lead sponsor:** Direction Centrale du Service de Santé des Armées
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-12-04
- **Primary completion:** 2025-10-17
- **Final completion:** 2025-10-20
- **Target enrollment:** 200 (ACTUAL)
- **Last updated:** 2026-01-26

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04431999

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04431999, "Evaluation of a Transfusion Therapy Using Whole Blood in the Management of Coagulopathy in Patients With Acute Traumatic Hemorrhage". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT04431999. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*